Present controversies in the treatment of schizophrenia.
D014150:Antipsychotic Agents / Q000627:therapeutic use; D002090:Butyrophenones / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D004565:Electroconvulsive Therapy; D005019:Ethyl Ethers / Q000627:therapeutic use; D005476:Fluphenazine / Q000627:therapeutic use; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D011572:Psychoanalysis; D011613:Psychotherapy; D012559:Schizophrenia / Q000628:therapy*; D014815:Vitamins / Q000627:therapeutic use
D014150:Antipsychotic Agents; D002090:Butyrophenones; D005019:Ethyl Ethers; D006845:Hydrocarbons, Fluorinated; D007328:Insulin; D014815:Vitamins; D005476:Fluphenazine; D002746:Chlorpromazine